PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.57%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
28.62%
Positive 5Y CAGR while PUK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
21.92%
Positive 3Y CAGR while PUK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
41.80%
Positive OCF/share growth while PUK is negative. John Neff might see a comparative advantage in operational cash viability.
-10.75%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-40.42%
Negative 10Y net income/share CAGR while PUK is at 53.15%. Joel Greenblatt sees a major red flag in long-term profit erosion.
671.79%
5Y net income/share CAGR above 1.5x PUK's 53.15%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
685.96%
3Y net income/share CAGR above 1.5x PUK's 11.39%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-24.85%
Negative equity/share CAGR over 10 years while PUK stands at 93.44%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
31.40%
Below 50% of PUK's 93.44%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
18.22%
Below 50% of PUK's 55.12%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
9.31%
Below 50% of PUK's 78.21%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
45.93%
3Y dividend/share CAGR similar to PUK's 50.69%. Walter Schloss finds parallel short-term dividend strategies for both companies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.